Poster Tour 6: Drug surveillance, harm reduction and priority populations
Tracks
.
| Tuesday, November 10, 2026 |
| 1:00 PM - 1:30 PM |
Speaker
APSAD 2026
Poster Tour 6: Introduction and Welcome
1:00 PM - 1:05 PMBiography
Kim Akrigg
Hdr Candidate
The University Of Queensland
Health Services Access and Harm Reduction Practices Among Women Who Use Image and Performance Enhancing Drugs: Findings from a Large International Sample
1:05 PM - 1:10 PMBiography
Kim Akrigg is an early career researcher at the University of Queensland with an interest in women's health and image and performance enhancing drugs.
Dr Christel Macdonald
Post-doctoral Research Fellow
National Drug and Alcohol Research Centre, UNSW
Factors Associated With Adult Incarceration Among People With Opioid Use Disorder in New South Wales, Australia
1:10 PM - 1:15 PMBiography
Dr Christel Macdonald is a Postdoctoral Research Fellow at NDARC, UNSW Sydney. She completed her PhD in March 2024 at NDARC. Christel's areas of research include mental health court diversion and treatment and intervention for people coming into contact with the criminal justice system.
Dr Jennifer Smith
Senior Research Fellow
University of Western Australia
What have we learned from five years of the Emerging Drugs Network of Australia, and how do we transition from a research-funded model to a sustainable toxicosurveillance system?
1:15 PM - 1:20 PMBiography
Jen is a Senior Research Fellow at the University of Western Australia and is the national coordinator of the Emerging Drugs Network of Australia (EDNA). Jen’s professional passion points and research experience are qualitative inquiry, evaluation methodology and harm reduction principles and practice.
Mr Stassi Kypri
PhD Candidate / Research Assistant
The National Centre for Clinical Research on Emerging Drugs
Reporting on drug alerts issued in Australia for 2025
1:20 PM - 1:25 PMBiography
Stassi Kypri is a PhD candidate and research assistant at the National Centre for Clinical Research on Emerging Drugs (NCCRED), UNSW, Sydney. His doctoral research involves a mixed-method exploration of ketamine and ketamine analogue use in Australia.
Dr Shady Abdelsalam
Phd Candidate
National Drug Research Institute - Curtin University
Assessing the impact of the Medically Supervised Injecting Room (MSIR) on levels of oral health in a cohort of people who inject drugs.
1:25 PM - 1:30 PMBiography
Dr Shady Abdelsalam is a PhD candidate at NDRI, with a passion for oral health, public health and research. His PhD project is titled “The impact of medically supervised injecting room (MSIR) utilisation on health outcomes in people who inject drugs”.
